Tag: clinical trials
An interview with Professor John Read who joins us to discuss the UK licensing of esketamine nasal spray (Spravato) for so-called ‘Treatment Resistant Depression’. John led a group of 12 academics and professionals who wrote to the UK regulator expressing concerns.
My heart goes out to anyone experiencing withdrawal but especially those surrounded by unsupportive judgemental people, and those who are so ill they can’t work and are struggling to navigate a heartless and cynical ‘benefits’ system. Denial and minimisation make it even more difficult for people to access help, support or seek understanding. Their only crime is to have experienced difficulty from a prescribed treatment, yet they are treated as medical pariahs.
We suggest there now ought to be an important debate as to whether criticism of CBT for psychosis has led to people who are distressed by experiences, such as hearing voices or other experiences of psychosis, being less likely to have been offered an effective intervention as a direct consequence.
An interview with psychiatrist, academic and author Dr Joanna Moncrieff, one of the founding members of the Critical Psychiatry Network. We talk about the recent meta-analysis of the efficacy and tolerability of 21 antidepressant drugs, widely reported in the UK news media on February 22nd.